Robert Francomano - Chief Commercial Officer at SELLAS Life Sciences Group, Inc.

Insider Transactions and Holdings

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class
Common Stock	40.9K	$256K	$6.25	Jan 22, 2024	Direct
Class A Common Stock	20.9K	$22.6K	$1.08	Dec 6, 2023	Direct
Stock Option (Right to Buy)	30K			Jan 22, 2024	Direct	Common Stock

Showing 1 to 3 of 3 entries

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.